Departamento académico
(FM) Inmunología
Publicacions (13) Publicacions en què ha participat algun/a investigador/a
2004
-
Acquired potential N-glycosylation sites within the tumor-specific immunoglobulin heavy chains of B-cell malignancies
Haematologica, Vol. 89, Núm. 5, pp. 541-546
-
Anti-inflammatory cytokines induce lipopolysaccharide tolerance in human monocytes without modifying toll-like receptor 4 membrane expression
Scandinavian Journal of Immunology, Vol. 59, Núm. 6, pp. 553-558
-
Biologic therapy of liver tumors
Surgical Clinics of North America, Vol. 84, Núm. 2, pp. 673-696
-
Imatinib Inhibits Proliferation of Ewing Tumor Cells Mediated by the Stem Cell Factor/KIT Receptor Pathway, and Sensitizes Cells to Vincristine and Doxorubicin-Induced Apoptosis
Clinical Cancer Research, Vol. 10, Núm. 2, pp. 751-761
-
Improving efficacy of interleukin-12-transfected dendritic cells injected into murine colon cancer with anti-CD137 monoclonal antibodies and alloantigens
International Journal of Cancer, Vol. 110, Núm. 1, pp. 51-60
-
Inmunidad y terapia génica: Beneficios y riesgos
Inmunologia, Vol. 23, Núm. 1, pp. 56-62
-
Inmunoterapia activa en el tratamiento de neoplasias hematológicas
Anales del sistema sanitario de Navarra, Vol. 27, Núm. 1, pp. 45-62
-
Lipopolysaccharide needs soluble CD14 to interact with TLR4 in human monocytes depleted of membrane CD14
Microbes and Infection, Vol. 6, Núm. 11, pp. 990-995
-
Pasado, presente y futuro de la vacunación anti-idiotipo.
Revista de medicina, Vol. 48, Núm. 3, pp. 14-23
-
Past, present and future of anti-idiotype vaccination
Revista de medicina de la Universidad de Navarra, Vol. 48, Núm. 3, pp. 14-23
-
Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors
Journal of Clinical Oncology, Vol. 22, Núm. 8, pp. 1389-1397
-
Tratamiento biológico de los tumores hepáticos
Clínicas quirúrgicas de Norteamérica, Vol. 2, pp. 633-654
-
Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: Implications for anti-idiotype vaccine development
Critical Reviews in Oncology/Hematology, Vol. 52, Núm. 1, pp. 1-7